Predictors of Immunological Failure after Initial Response to Highly Active Antiretroviral Therapy in HIV‐1–Infected Adults: A EuroSIDA Study

200464 citationsJournal Articlebronze Open Access

Authors

Ulrik Bak Dragsted · Hvidovre Hospital

Amanda Mocroft · The Royal Free Hospital

Stefano Vella · Istituto Superiore di Sanità

Jean‐Paul Viard · Hôpital Necker-Enfants Malades

Ann‐Brit Eg Hansen · Rigshospitalet

George Panos · iKnowHow (Greece)

D Mercey ·

Abstract

The risk of immunological failure in patients with an immunological response to HAART diminishes with a longer time receiving treatment and is associated with pretreatment CD4(+) cell count, ongoing viral replication, and intravenous drug use.

Topics & Keywords

HIV/AIDS Research and Interventions HIV Research and Treatment HIV/AIDS drug development and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Infectious Diseases

Volume 190, Issue 1, pp. 148-155

DOI: 10.1086/420786

Field-Weighted Citation Impact: 2.74